AxoGen (AXGN)
NASDAQ:AXGN

AxoGen Stock Price & Analysis

338 Followers

AXGN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$6.87 - $13.66
Previous Close$11.09
Volume106.52K
Average Volume (3M)250.11K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$53.11M
Total Debt (Recent Filing)$67.65M
Price to Earnings (P/E)-16.1
Beta0.22
Next EarningsFeb 20, 2023
Dividend YieldN/A
EPS (TTM)-0.69
Shares Outstanding42,286,590
R-Squared0.03
Standard Deviation0.16
10 Day Avg. Volume259,102
30 Day Avg. Volume250,106
Price to Book (P/B)4.79
Price to Sales (P/S)3.50
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-11.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside60.05% Upside
Rating ConsensusStrong Buy
Alpha-0.00640
Number of Analyst Covering5


Financials


Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

AXGN FAQ

What was AxoGen’s price range in the past 12 months?
AxoGen lowest stock price was $6.87 and its highest was $13.66 in the past 12 months.
    What is AxoGen’s market cap?
    Currently, no data Available
    When is AxoGen’s upcoming earnings report date?
    AxoGen’s upcoming earnings report date is Feb 20, 2023 which is in 77 days.
      How were AxoGen’s earnings last quarter?
      AxoGen released its earnings results on Nov 08, 2022. The company reported -$0.01 earnings per share for the quarter, beating the consensus estimate of -$0.126 by $0.116.
        Is AxoGen overvalued?
        According to Wall Street analysts AxoGen’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does AxoGen pay dividends?
          AxoGen pays a Notavailable dividend of $1 which represents an annual dividend yield of N/A. AxoGen’s last Notavailable dividend payment was on Feb 12, 2010. AxoGen’s upcoming ex-dividend date is Jan 27, 2010
            What is AxoGen’s EPS estimate?
            AxoGen’s EPS estimate is -$0.11.
              How many shares outstanding does AxoGen have?
              AxoGen has 42,286,590 shares outstanding.
                What happened to AxoGen’s price movement after its last earnings report?
                AxoGen reported an EPS of -$0.01 in its last earnings report, beating expectations of -$0.126. Following the earnings report the stock price went up 12.921%.
                  Which hedge fund is a major shareholder of AxoGen?
                  Among the largest hedge funds holding AxoGen’s share is Perceptive Advisors LLC. It holds AxoGen’s shares valued at 11M.

                    ---

                    AxoGen Stock Smart Score

                    8
                    Outperform
                    1
                    2
                    3
                    4
                    5
                    6
                    7
                    8
                    9
                    10

                    Technicals

                    SMA
                    Positive
                    20 days / 200 days
                    Momentum
                    9.69%
                    12-Months-Change

                    Fundamentals

                    Return on Equity
                    -26.59%
                    Trailing 12-Months
                    Asset Growth
                    -6.88%
                    Trailing 12-Months
                    The AxoGen stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    AxoGen

                    AxoGen, Inc. engages in the development and market of surgical solutions for peripheral nerves. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.

                    ---

                    Forecast EPS vs Actual EPS


                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Inogen
                    Sight Sciences
                    SurModics
                    AngioDynamics
                    Artivion

                    Popular Stocks

                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis